Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.
The ability of the selective 5-HT3 receptor antagonist ondansetron to influence the behavioural consequences of withdrawal from chronic treatment with ethanol, nicotine or cocaine was investigated in the light/dark exploration test in the mouse and social interaction test in the rat. In both tests acute and chronic (7 days) treatments with ondansetron (0.01-1.0 microgram.kg-1 IP) disinhibited suppressed behaviour; withdrawal from chronic treatment (0.1 mg/kg IP b.i.d.) did not exacerbate the behavioural suppression. Chronic treatment for 14 days with ethanol (8% w/v in the drinking water), nicotine (0.1 mg/kg b.i.d.) or cocaine (1.0 mg/kg b.i.d.) released suppressed behaviour in the mouse and rat tests. Behavioural suppression was increased following withdrawal from ethanol, nicotine and cocaine. The administration of ondansetron (0.01 mg/kg IP b.i.d.) during the period of ethanol, nicotine and cocaine withdrawal prevented the exacerbation in suppressed behaviour. It is concluded that ondansetron potently reduces behavioural suppression during acute and chronic treatments in the rodent models, does not cause a rebound exacerbation of behavioural suppression following withdrawal, and is a highly effective inhibitor of the increased behavioural suppression following withdrawal from the drugs of abuse: ethanol, nicotine and cocaine.
Costall
B
B
Postgraduate Studies in Pharmacology, School of Pharmacy, University of Bradford, U.K.
Jones
B J
BJ
Kelly
M E
ME
Naylor
R J
RJ
Onaivi
E S
ES
Tyers
M B
MB
D000818:Animals; D003042:Cocaine / Q000633:toxicity; D000431:Ethanol / Q000633:toxicity; D005106:Exploratory Behavior / Q000187:drug effects*; D013287:Illicit Drugs / Q000633:toxicity*; D007093:Imidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D051379:Mice; D009538:Nicotine / Q000633:toxicity; D017294:Ondansetron; D051381:Rats; D011919:Rats, Inbred Strains; D012702:Serotonin Antagonists; D012919:Social Behavior; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control*
D013287:Illicit Drugs; D007093:Imidazoles; D012702:Serotonin Antagonists; D000431:Ethanol; D017294:Ondansetron; D009538:Nicotine; D003042:Cocaine